A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.(See HF 2456.)
Impact
The enactment of HF2252 would significantly influence state regulations concerning pharmacy practices and accessibility. By formalizing the requirement for accessible prescription labels and medical information, the bill not only promotes inclusivity in healthcare but also aligns with federal guidelines as outlined in relevant government reports focusing on best practices for accessibility. This initiative is expected to bridge the gap in information access that individuals with disabilities face, thereby enhancing their healthcare experience and decision-making capabilities.
Summary
House File 2252 is a legislative proposal that focuses on improving access to prescription-related information for individuals who are blind, have visual impairments, or otherwise have print disabilities. The bill mandates that the board of pharmacy develop and implement administrative rules by October 31, 2024, to ensure that accessible prescription drug labels, bag tags, and medical guides are available at no additional cost to these individuals. The legislation aims to eliminate barriers that currently prevent access to critical healthcare information, ensuring that the information is provided in formats that are easily understandable and usable for those with disabilities.
Contention
While the bill appears largely beneficial, discussions and comments from stakeholders could reveal some points of contention, particularly regarding the implementation costs and responsibilities tied to the regulations. It may raise concerns from pharmacies regarding compliance costs and operational adjustments necessary to accommodate the new requirements. Additionally, there may be debates on the adequacy of guidelines specified for determining what constitutes accessibility, and whether these measures will effectively meet the needs of individuals across different disabilities.
Similar To
A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.
Similar To
A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.(Formerly HF 2252.)
A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.
A bill for an act relating to the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or other print disability.(See HF 2585.)
A bill for an act relating to the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or other print disability. (Formerly HF 2033.) Effective date: 07/01/2026.
Provides for eligibility for medical assistance for personal care services for persons with traumatic brain injury, developmental disability, cognitive impairments, blindness or visual impairment.
Establishing the blind information access act to require the state library to provide on-demand information access services to persons who are blind, visually impaired, deafblind or print disabled.
Establishing the blind information access act to require the state library to provide on-demand information access services to persons who are blind, visually impaired, deafblind or print disabled.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.